Variations of Surveillance Practice for Patients with Bone Sarcoma: A Survey of Australian Sarcoma Clinicians

Table 3

Approach to end of treatment radiological assessment.

	PO	Med Onc	Radiation	Ortho	value	OR	OR 95% CI
Number of responses	23	10	9	7
End of treatment response assessment
Local disease
X-ray	20 (87%)	3 (30%)	2 (22%)	2 (29%)	<0.001	14.78	[]
CT	5 (22%)	2 (20%)	1 (11%)	2 (29%)	1.00	0.97	[]
MRI	18 (78%)	7 (70%)	9 (100%)	6 (86%)	0.72	0.63	[]
FDG-PET	16 (70%)	5 (50%)	7 (78%)	3 (43%)	0.56	1.56	[]
Bone scan	6 (26%)	0 (0%)	0 (0%)	1 (14%)	0.12	4.28	[]
Metastatic disease
CXR	7 (30%)	0 (0%)	0 (0%)	0 (0%)	0.02	10.87	[]
CT chest	23 (100%)	5 (50%)	5 (56%)	4 (57%)	<0.001		[
CT chest/abdomen/pelvis	1 (4%)	4 (40%)	3 (33%)	3 (43%)	0.006	0.07	[]
FDG-PET	15 (65%)	8 (80%)	7 (78%)	4 (57%)	0.55	0.66	[]
Whole body scintigraphy	5 (22%)	0 (0%)	0 (0%)	1 (14%)	0.23	3.39	[]
Whole body MRI	0 (0%)	0 (0%)	0 (0%)	0 (0%)	1.00		[]
Bone marrow aspirate	6 (26%)	0 (0%)	0 (0%)	0 (0%)	0.006		[

due to insufficient data.
value represents comparison between PO and NP.